Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion. [PDF]
J Clin Neurol, 2023 Background and Purpose Neurogenic orthostatic hypotension (nOH) is one of the most important nonmotor symptoms in patients with α-synucleinopathies. Atomoxetine is a selective norepinephrine transporter blocker that is a treatment option for nOH.
Jung YJ, Kim A, Okamoto LE, Hong WH.
europepmc +3 more sources
Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family. [PDF]
Clin Auton Res, 2023 Purpose Orthostatic hypotension is a common condition with heterogeneous and, in many cases, unclear underlying pathophysiology. Frequent symptoms are syncope and falls with a strong impact on daily life.
Fagius J, Klar J, Dahl N.
europepmc +4 more sources
Current Landscape of Compression Products for Treatment of Postural Orthostatic Tachycardia Syndrome and Neurogenic Orthostatic Hypotension. [PDF]
J Clin MedBackground/Objectives: Patients with postural orthostatic tachycardia syndrome (POTS) or neurogenic orthostatic hypotension (nOH) experience vertigo, confusion, and syncope.
Mitra K +6 more
europepmc +3 more sources
ODP291 A Series of COVID Reinfections in a Vaccinated Patient leading to Development of Neurogenic Orthostatic Hypotension and Postural Orthostatic Tachycardia [PDF]
J Endocr Soc, 2022 The recently recognized 'long COVID' syndrome, encompasses symptoms of shortness of breath, chest pain, palpitations and orthostatic intolerance which can last for weeks or more following even mild illness.
Clio Musurakis +2 more
europepmc +4 more sources
Neurogenic Orthostatic Hypotension in Parkinson Disease-A Narrative Review of Diagnosis and Management. [PDF]
J Clin MedBackground: Neurogenic orthostatic hypotension (NOH) is a significant non-motor manifestation of Parkinson’s disease (PD), that substantially affects patient disability and has a powerful impact on the quality of life of PD patients, while also ...
Grosu C +4 more
europepmc +3 more sources
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson's disease. [PDF]
Clin Auton ResPurpose Neurogenic orthostatic hypotension (nOH) and gait impairment are frequent sources of disability in Parkinson’s disease (PD). However, the impact of nOH on balance and gait features remains unclear.
Imbalzano G +8 more
europepmc +3 more sources
Effects of Daily Lifestyle Habits on Non-Neurogenic Orthostatic Hypotension in Older Adults in South Korea: A Cross-Sectional Study. [PDF]
Healthcare (Basel)Background: Orthostatic hypotension (OH) is a chronic, debilitating condition common in older adults. This study examined the effects of daily lifestyle habits on non-neurogenic OH in older adults in South Korea.
Kim N, Oh HK.
europepmc +3 more sources
Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension. [PDF]
Clin Auton Res, 2021 <jats:title>Abstract</jats:title><jats:p>GNSS satellite and receiving antennas exhibit group delay variations (GDV), which affect code pseudorange measurements. Like antenna phase center variations, which affect phase measurements, they are frequency-dependent and vary with the direction of the transmitted and received signal.
Eisenhofer G, Goldstein DS.
europepmc +7 more sources
Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial. [PDF]
Clin Auton ResPurpose We previously reported that single doses of the norepinephrine transporter inhibitor, atomoxetine, increased standing blood pressure (BP) and ameliorated symptoms in patients with neurogenic orthostatic hypotension (nOH). We aimed to evaluate the
Mwesigwa N +9 more
europepmc +3 more sources
A validated test for neurogenic orthostatic hypotension at the bedside. [PDF]
Ann Neurol, 2018 Norcliffe-Kaufmann L +2 more
europepmc +5 more sources